Literature DB >> 22123235

Metabolic diseases and cancer risk.

Malin H Faulds1, Karin Dahlman-Wright.   

Abstract

PURPOSE OF REVIEW: Metabolic disease and cancer are two of the leading causes of death worldwide. This review focuses on the potential increased relative risk for the development of cancer in a population with a rapidly increasing incidence of metabolic disturbances. RECENT
FINDINGS: A large number of recent epidemiological and prospective studies link metabolic syndrome-associated diseases to an increased risk for development of, as well as mortality from, several types of cancer. In patients diagnosed with metabolic disorders, the incidence of gastrointestinal, glandular and reproductive tract cancers is significantly higher compared to the general population. In line with that, hyperglycemia has recently been shown to be an independent risk factor for overall cancer incidence.
SUMMARY: Disorders connected to the metabolic syndrome have been shown to have profound impacts on the incidence and progression of cancer. Continued efforts to make lifestyle interventions, such as weight loss and increased physical activity in the general population, are clearly warranted as a contribution to efforts aimed at decreasing the development of and mortality from cancer. Progression in this field requires a better understanding of the underlying mechanisms behind the cancer-promoting effects associated with disturbed energy balance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22123235     DOI: 10.1097/CCO.0b013e32834e0582

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  31 in total

Review 1.  Brain metabolic dysfunction at the core of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Ming Tong
Journal:  Biochem Pharmacol       Date:  2013-12-28       Impact factor: 5.858

Review 2.  Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal.

Authors:  Rajat Sandhir; Smriti Gupta
Journal:  World J Diabetes       Date:  2015-09-25

3.  Clinical and Metabolic Response to Vitamin D Supplementation in Endometrial Hyperplasia: a Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Zohreh Tabassi; Sedigheh Bagheri; Mansooreh Samimi; Hamid Reza Gilasi; Fereshteh Bahmani; Maryam Chamani; Zatollah Asemi
Journal:  Horm Cancer       Date:  2017-03-10       Impact factor: 3.869

Review 4.  Lipids and prostate cancer.

Authors:  Janel Suburu; Yong Q Chen
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-04-05       Impact factor: 3.072

Review 5.  Gut bacteria and cancer.

Authors:  Susan E Erdman; Theofilos Poutahidis
Journal:  Biochim Biophys Acta       Date:  2015-06-04

6.  Steroid Hormones and the Physiological Regulation of Tissue-Resident Stem Cells: Lessons from the Drosophila Ovary.

Authors:  Elizabeth T Ables; Daniela Drummond-Barbosa
Journal:  Curr Stem Cell Rep       Date:  2017-02-01

Review 7.  Relationships between diabetes and cognitive impairment.

Authors:  Suzanne M de la Monte
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

8.  Presentation, diagnostic features and glucose handling in a monocentric series of insulinomas.

Authors:  M Toaiari; M V Davì; L Dalle Carbonare; L Boninsegna; C Castellani; M Falconi; G Francia
Journal:  J Endocrinol Invest       Date:  2013-04-18       Impact factor: 4.256

Review 9.  Metabolism and breast cancer risk: frontiers in research and practice.

Authors:  Ruth E Patterson; Cheryl L Rock; Jacqueline Kerr; Loki Natarajan; Simon J Marshall; Bilge Pakiz; Lisa A Cadmus-Bertram
Journal:  J Acad Nutr Diet       Date:  2012-11-03       Impact factor: 4.910

Review 10.  Type 2 diabetes: prevalence and relevance of genetic and acquired factors for its prediction.

Authors:  Wolfgang Rathmann; Christa Scheidt-Nave; Michael Roden; Christian Herder
Journal:  Dtsch Arztebl Int       Date:  2013-05-10       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.